| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Networking > Keep It Alive, Part 1: Using Email to Stay in Touch with Your Network |
|
Digg It - Keep It Alive, Part 1: Using Email to Stay in Touch with Your Network
Guess what? Today you will be taking field trip! No permission slip needed. THE DESTINATION: your inbox. Here’s your fir According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product st assignment: Start by going back to your oldest saved email message. Maybe it’s from last year. Maybe it’s from ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in last month. Maybe it’s from last century. But spend the next half-hour working your way backwards to today. By reviewing pas lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. t emails, you’ll come across people, messages and issues you’ve completely forgotten all about. You might think, “Wow, I wonde here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe what Karen’s been up to lately!” or “Hmm…I don’t recognize Mike’s name. Better re-read his message to refresh my memory.” Ei d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro her way, this trip down e-memory lane is the perfect exercise to workout those out of shape networking muscles. And if you can ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc reconnect with just one person you otherwise wouldn’t have talked to, it will be worth it. OK. Here’s your second assignm easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nt: Another underused feature for staying in touch is the email auto-completer. Depending on which mail client you use, y nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ou should be able to do this in a few quick steps: 1. Go to “compose new message.” 2. Punch in any letter of the alphab and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ t. 3. You should be prompted with a dozen or so potential email addresses starting with that same letter. Pick a name a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi d email away! It’s actually kind of fun. You’ll see names you completely forgot about! Gmail is good at this. They prov ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ide you with a drop down box. It reminds you of every person you’ve ever emailed (or received an email from) over the years. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod RY THIS: every once in a while, take a few minutes and just go through the entire alphabet. You never know whose name might co cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin me up! And a simple, “We haven’t chatted in a while, so I just thought I’d drop a line and say hey!” is the perfect way to rec tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nnect with an old friend or colleague. Ultimately, running a monthly email search is the perfect tool to Keep It Alive with ol t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel contacts, friends and prospects. Maybe it’s a simple “just checking in” note. Maybe it’s a reply to an old message you ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust forgot about. Maybe it’s an email update to an old friend you haven’t talked to in a while. EITHER WAY: people w y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ll appreciate your follow up. PLUS, YOU NEVER KNOW: you might make a sale, reconnect with old friends, even made someone’s day . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ! AND SURE, it might seem like extra work. But remember, the last four words in N-E-T-W-O-R-K are W-O-R-K! LET ME ASK YA THI elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ... How do you keep it alive? LET ME SUGGEST THIS... Email me your best Keep It Alive technique for a future article tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Essential Office Equipment for a Home Business Self-Analysis Is Good For The Soul
|